Unlike in our previous study on patients with primary biliary cholangitis (PBC)11 we detected no inhibition of CYP7A1 expression, which is a key mechanism involved in reducing hepatic BA synthesis. The gene discussed is CYP7A1; the disease is biliary liver cirrhosis.